Kurata Lance 4

4 · Arcturus Therapeutics Holdings Inc. · Filed Aug 12, 2020

Insider Transaction Report

Form 4
Period: 2020-08-10
Kurata Lance
Chief Legal Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-08-10+90,00090,000 total
    Exercise: $58.91Exp: 2030-08-09Common Stock (90,000 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying the option vest on August 10, 2021, with the remainder vesting in 36 successive equal monthly increments thereafter.

Documents

1 file
  • 4
    e619870_4-kurata.xmlPrimary